Wound recurrence following laparoscopic colon cancer resection

Vukasin, Petar; Ortega, Adrián E.; Greene, Frederick L.; Steele, Glenn; Simons, A. J.; Anthone, Gary J.; Weston, Lynn A.; Beart, Robert W.

doi:10.1007/bf02053801

Cited by 209 publications

(70 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Disturbingly, these recurrences are not restricted to tumors in advanced stages (as in most cases of abdominal wall recurrences following laparotomy) but have also occurred after laparoscopy for early carcinomas [40]. Various theories have been proposed and investigated to explain this phenomenon, relying on both clinical experience and experimental models [38,52,54]. Possible causes include direct implantation of the port-site by exfoliated cancer cells, hematogenous seeding, tissue manipulation, aerosolization by pneumoperitoneum, patient positioning, and immune dysfunction.…”

Section: Laparoscopy For Tmementioning

confidence: 95%

Laparoscopic total mesorectal excision

et al. 2002

View full text Add to dashboard Cite

After total mesorectal excision for rectal cancer was introduced in 1982, local recurrence rates decreased to 5%. These results were found to be reproducible; therefore, the technique became standard for the treatment of rectal cancer. Laparoscopic surgery for curable colorectal malignancy is still considered investigational. Indeed, the United States National Cancer Institute (NCI) trial excludes rectal carcinoma. The application of laparoscopy to rectal carcinoma must compete with total mesorectal excision, which has obtained favorable results in the last decade. In this review, we assess the adequacy of laparoscopic total mesorectal excision, describe the techniques (both anterior resection and abdominoperineal resection), and discuss their potential advantages.

show abstract

Section: Laparoscopy For Tmementioning

confidence: 95%

Laparoscopic total mesorectal excision

et al. 2002

View full text Add to dashboard Cite

show abstract

“…Based on the more recent reports [10,12,13,[61][62][63] of larger operative series, the incidence of port site recurrence dropped to 0 to 1.1%. Because the criteria for patient selection and indication of surgery might be different among institutions and most studies were not randomized or prospective in nature, it is rather difficult to compare the results directly.…”

Section: Incidence Of Port-site Recurrencementioning

confidence: 99%

Laparoscopic Surgery of the Colon and Rectum

1999

View full text Add to dashboard Cite

The use of laparoscopic techniques in benign colorectal surgery has expanded over the past several years, but controversy continues to surround the use of laparoscopic resection in cases of colorectal carcinoma. Diagnostic laparoscopy, the creation of stomas, and limited resections are becoming reasonable indications for benign diseases. In cases of malignancy, resection through a conventional incision or a laparoscope must adhere to the same defined surgical oncologic principles. Current randomized trials comparing open resection to laparoscopic resection should address these concerns. Port-site recurrence remains a leading concern regarding the widespread acceptance of laparoscopic resection for colorectal carcinoma. This article focuses on the applications of laparoscopic colorectal surgery for malignant diseases. Further research in this area combined with advances in laparoscopic technology will be critical to the future successful application of laparoscopic surgery to colorectal carcinoma.

show abstract

“…LS is now widely accepted in the treatment of benign colorectal diseases including diverticulitis, familial adenomatous polyposis, and Crohn's disease [8]. However, the role of LS in the treatment of malignant disease remains controversial because of concerns about the adequacy of lymphadenectomy, early reports of port site recurrences, and the lack of long-term survival data [6,14]. The studies published to date report only short-term outcomes of LS for colorectal cancer [3,4,5].…”

mentioning

confidence: 97%